Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Raptiva recommended for approval by advisory committee

Sep. 15, 2003

Inhibitors of procollagen C-endopeptidase synthesized and evaluated as potential antifibrotic agents

Sep. 12, 2003

Phase I trial evaluates Psoraxine for psoriasis

Sep. 12, 2003

Continued development of QR-337 to be conducted under IND

Sep. 8, 2003

Elidel studies reveal patient satisfaction with eczema treatment

Sep. 8, 2003

New glucocorticoids for inflammatory and allergic disorders covered by GSK patent

Sep. 5, 2003

Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia

Aug. 26, 2003

CX-659S prevents rebound after prednisolone treatment

Aug. 25, 2003

Genzyme submits regulatory submission for Hylaform

Aug. 21, 2003

New hair growth-promoting agents prepared and tested at Kao

Aug. 20, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....